PCMI
GNMK
Paradigm Capital Management Inc’s GenMark Diagnostics, Inc GNMK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-733,300
| Closed | -$17.5M | – | 155 |
|
|
2021
Q1 | $17.5M | Buy |
733,300
+112,500
| +18% | +$2.69M | 0.91% | 37 |
|
|
2020
Q4 | $9.06M | Buy |
620,800
+424,700
| +217% | +$6.2M | 0.54% | 49 |
|
|
2020
Q3 | $2.79M | Buy |
196,100
+2,400
| +1% | +$34.1K | 0.23% | 77 |
|
|
2020
Q2 | $2.85M | Buy |
193,700
+75,000
| +63% | +$1.1M | 0.26% | 75 |
|
|
2020
Q1 | $489K | Buy |
118,700
+18,600
| +19% | +$76.6K | 0.06% | 116 |
|
|
2019
Q4 | $481K | Buy |
100,100
+55,400
| +124% | +$266K | 0.04% | 133 |
|
|
2019
Q3 | $271K | Buy |
44,700
+25,000
| +127% | +$152K | 0.02% | 141 |
|
|
2019
Q2 | $127K | Hold |
19,700
| – | – | 0.01% | 155 |
|
|
2019
Q1 | $140K | Hold |
19,700
| – | – | 0.01% | 160 |
|
|
2018
Q4 | $96K | Hold |
19,700
| – | – | 0.01% | 157 |
|
|
2018
Q3 | $144K | Buy |
19,700
+4,800
| +32% | +$35.1K | 0.01% | 168 |
|
|
2018
Q2 | $95K | Buy |
+14,900
| New | +$95K | 0.01% | 162 |
|